Apixaban Versus Warfarin for the Management of Post-operative Atrial Fibrillation

Recruiting

Phase 2/3 Results N/A

Summary of Purpose

In this open-label, prospective, randomized pilot study, patients who develop atrial fibrillation after isolated coronary artery bypass grafting surgery will be identified. Patients with persistent atrial fibrillation (>12 hours) or recurrent sustained atrial fibrillation (>2 episodes of atrial fibrillation lasting longer than 30 minutes) will be candidates for inclusion. Upon meeting study inclusion and...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 28 June 2017.

1 Sep 2016 30 Aug 2016 1 Dec 2018 1 Dec 2018 1 Jun 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Prevention
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts